Page last updated: 2024-09-03

y 27632 and bohemine

y 27632 has been researched along with bohemine in 2 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(bohemine)
Trials
(bohemine)
Recent Studies (post-2010) (bohemine)
1,92438913007

Protein Interaction Comparison

ProteinTaxonomyy 27632 (IC50)bohemine (IC50)
G2/mitotic-specific cyclin-B2Homo sapiens (human)1.1
Cyclin-dependent kinase 1Homo sapiens (human)1.8
G2/mitotic-specific cyclin-B1Homo sapiens (human)1.1
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)1.65
G1/S-specific cyclin-E1Homo sapiens (human)1.65
Cyclin-dependent kinase 2Homo sapiens (human)1.3667
G2/mitotic-specific cyclin-B3Homo sapiens (human)1.1
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)1.65

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1

Other Studies

2 other study(ies) available for y 27632 and bohemine

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013